US Market Report for Anesthesia Information Management Systems 2017 – MedCore

US Market Report for Anesthesia Information Management Systems 2017 – MedCore

0

The market for AIMS was slow to develop but after a number of funding acts and governmental penalties imposed on facilities failing to utilize an AIMS the market has demonstrated a high level of growth. Specifically governmental penalties were issued for hospitals not using an electronic medical record system (EMR), with AIMS being a form of one, that decreased Medicare/Medicaid reimbursement for covered patients to providers and hospitals that failed to use an EMR by 2015. This in turn generated growth which is set to stabilize in the market over time. Overall, the AIMS market in the hospital setting is far larger relative to the ASC market, which corresponds to the relative volumes of anesthesia procedures done as an aggregate in each setting.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 230
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
Anesthesia information management systems (AIMS) collect patient data digitally and use it to facilitate the anesthesia management of patients. AIMS are installed on a variety of hardware setups ranging from a simple laptop-like clinical workstation to more advanced and expensive touch-screen-based systems. All AIMS require networking between a central server used to store patient data and client side workstations within each operating room that link up to monitors and delivery machines to collect data.
There are several components that factor into the cost of establishing an AIMS in a hospital or ASC, the most significant of which is the software license and associated cost of integrating the newly installed AIMS with other hospital information systems that may or may not be provided by the same company. Additional factors include maintenance and support costs, which are frequently paid upfront by the institution to cover maintenance for a fixed number of years, as well as hardware costs associated with the installation of servers and work stations. Because maintenance and support costs are in many cases paid over time, and are therefore not factored into the initial setup and installation fees, this report focuses exclusively on the software, integration and hardware costs linked to the initial installation of the AIMS.
AIMS have many documented benefits to hospitals and anesthesia departments; in particular, improving efficiency and record keeping in the hospital operating room (OR), typically the most costly suite in the hospital. In that regard, the minimization of costs in the OR is important to hospital organizations maintaining a healthy bottom line. The implementation of AIMS has been shown to financially benefit hospital management by minimizing waste of anesthesia-related drugs, streamlining billing, capturing anesthesia charges and increasing reimbursement gained through improved hospital coding. Clinicians benefit from more comprehensive decision support tools, improved patient care and safety support, enhancement of clinical quality improvement programs and clinical studies, and support of clinical risk management. Proper utilization of AIMS can also help prevent possible malpractice and controlled-substance diversion cases by providing a solid electronic record of an anesthesiologist’s treatment of a patient, as well as a record of which anesthetic drugs were administered and when. Early adopters of this software were large, academic teaching hospitals, but smaller community hospitals are expected to greatly increase their adoption of AIMS in the future because of the clearly defined and understood benefits of these record-keeping solutions.



The "US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Philips Respironics
ResMed
CAIRE Inc.
Becton Dickinson
GE Healthcare
Covidien
DeVilbiss
Invacare
Dr?ger
Teleflex
Fisher & Paykel
Inogen
Smiths Medical
Ambu
Mindray
Omron
Maquet
Westmed
Natus Medical
Others include: Airgas, BD-CareFusion, Cramer Decker, eVent, Flexicare, Flotec, Fukuda Denshi, GE Healthcare, Global Medical Holdings, Graham Field, Intersurgical, Invacare, Mada Medical, Maquet, Massimo, Medis, Mercury Medical, Metal Impact, Nellcor, Nidek, O2 Concepts, Oxlife, Penlon, Percussionaire, Philips Respironics, Sechrist, Somnostar, Spacelabs, SunMed, Teleflex, Ventlab, VisionAire, Welch Allyn, Zoll, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link